[Modern development of chemotherapy and their significance for bacterial diseases of the skin].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D003227:Conjugation, Genetic; D004338:Drug Combinations; D004794:Enzyme Repression; D004917:Erythromycin / Q000627:therapeutic use; D005827:Genetics, Microbial; D008034:Lincomycin / Q000627:therapeutic use; D008297:Male; D008967:Molecular Biology; D009154:Mutation; D009355:Neomycin / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000008:administration & dosage; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D004338:Drug Combinations; D010406:Penicillins; D004917:Erythromycin; D002701:Chloramphenicol; D014295:Trimethoprim; D008034:Lincomycin; D013752:Tetracycline; D009355:Neomycin; D013420:Sulfamethoxazole
Moderne Entwicklungen der Chemotherapie in ihrer Bedeutung für bakterielle Erkrankungen der Haut